Univax Biologics Inc. announced Monday that it has filed withthe Securities and Exchange Commission (SEC) for a secondaryoffering of 2.5 million shares of common stock, with anoverallottment option of 375,000 shares. Managingunderwriters for the offering are Prudential Securities Inc. andMontgomery Securities.
Univax completed an initial public offering last February,grossing $48 million with 4 million shares at $12 per share.After the IPO, the company (NASDAQ:UNVX) had 11,074,103shares outstanding. The company's stock closed Monday at$9.75, down $1 a share.
(c) 1997 American Health Consultants. All rights reserved.